The Crucial Role of Initial Tests in Mesothelioma Treatment
| | |

The Crucial Role of Initial Tests in Mesothelioma Treatment

Mesothelioma diagnosis and treatment begin with a series of initial tests to determine the specific type of the disease. A recent study explored these tests and their accuracy in predicting mesothelioma types. Discover why getting it right from the start can be a matter of life and death for mesothelioma patients. Prognosis and Treatment Mesothelioma is a type of cancer that affects the lining of the lungs and other organs. Doctors often use surgery to remove the cancer. In some cases, they also use chemotherapy before the surgery to shrink the tumor. Before starting treatment, doctors conduct tests to figure out what type of mesothelioma their patient has. A recent study looked at how accurate the initial tests were in…

Mesothelioma Treatment Roadmap: Connecting Chemotherapy Response and Surgical Outcomes
| |

Mesothelioma Treatment Roadmap: Connecting Chemotherapy Response and Surgical Outcomes

Mesothelioma patients who do not respond well to chemotherapy before surgery are likely to have poor outcomes after the procedure. This is the finding of a group of researchers from the University of Texas MD Anderson Cancer Center. How Chemotherapy Response Shapes Mesothelioma Surgery Outcomes Mesothelioma is a rare type of cancer that is hard to diagnose and treat. It develops from the thin layer of tissue that covers many of the body’s internal organs. Mesothelioma is caused by exposure to a toxic mineral called asbestos. In most cases, doctors will use more than one type of treatment to remove as many cancer cells as possible from a patient’s body. The standard therapies include chemotherapy, radiation, and surgery. Of all…

How Photodynamic Therapy is Changing the Game for Mesothelioma Patients
|

How Photodynamic Therapy is Changing the Game for Mesothelioma Patients

When it comes to treating a tough cancer like malignant pleural mesothelioma, doctors use many different methods. One important way is surgery to remove the big parts of the disease. Researchers from the University of Pennsylvania have been studying how another treatment called photodynamic therapy (PDT) can help during surgery. PDT is a special light treatment has shown potential in animal studies. Surgery and PDT can work together to help mesothelioma patients. Combining Surgery and PDT for Optimal Treatment Mesothelioma is a rare but deadly cancer caused by asbestos exposure. Pleural mesothelioma occurs on the membrane around the lungs. It is the most common type of mesothelioma. Around 2,500 Americans receive a mesothelioma diagnosis each year. There is no cure. Surgery plays…

Saving Lives and Lung Tissue: The Ideal Surgical Approach for Mesothelioma
|

Saving Lives and Lung Tissue: The Ideal Surgical Approach for Mesothelioma

New research has outlined the ideal approach to surgery for treating mesothelioma. The news comes from Hyogo Medical University in Japan. Since surgery is just one part of the treatment plan, it is important to focus on saving the lung tissue as much as possible. After the surgery, the patient’s quality of life should be the top priority, especially when they need other treatments. Improving Mesothelioma Treatment Outcomes Mesothelioma is a type of cancer that is caused by exposure to asbestos. When asbestos fibers get into the lining of the lungs, it can cause the tissue to become inflamed and grow tumors. The usual treatment strategy for mesothelioma includes multiple types of therapies. The treatment plans usually include surgery, chemotherapy,…

Predicting Mesothelioma Survival with Advanced Techniques
|

Predicting Mesothelioma Survival with Advanced Techniques

A team of scientists is working on developing a way to predict the survival of mesothelioma patients. In particular, those who are treated with a specific type of surgery and chemotherapy. The prediction tool would work for patients with peritoneal mesothelioma. This is a type of mesothelioma that grows in the lining of the abdominal cavity. Peritoneal mesothelioma is caused by asbestos. Peritoneal mesothelioma occurs in less than 1,000 people in the United States every year. Most of these people are over the age of 65, but it can also develop in people who are much younger. Symptoms associated with peritoneal mesothelioma may take decades after asbestos exposure to appear. They are usually noticed first in the stomach or intestinal…

Promising Results of CRS/HIPEC Treatment
| | |

Promising Results of CRS/HIPEC Treatment

A new treatment can lead to good short- and long-term outcomes for patients with mesothelioma. It’s called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Research results came from the Medical University of Vienna in Austria. They looked at the first 100 mesothelioma patients who had this treatment in their hospital. Advancing Mesothelioma Care Mesothelioma is a rare form of cancer that grows in the lining that covers many of the internal organs of the body. Mesothelioma is caused by exposure to asbestos. There are approximately 2,000 cases of mesothelioma diagnosed in the United States every year. The standard treatment for mesothelioma usually includes surgery, chemotherapy, and radiation. The typical prognosis with standard treatment is survival between one and five years….

Mesothelioma Surgery is Now Much Safer
| |

Mesothelioma Surgery is Now Much Safer

Doctors have made huge improvements on a procedure called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). This is positive news for people for malignant peritoneal mesothelioma. Surgery as a Treatment CRS/HIPEC is a surgery that is used to treat cancers that are found on the surface of organs in the stomach area. This includes malignant peritoneal mesothelioma (MPM). MPM is an aggressive cancer caused by asbestos. The cancer grows on the lining of the abdominal cavity. Symptoms of MPM are usually noticed first in the stomach area. People might feel abdominal pain or swelling, fever, and night sweats. MPM is the second most common form of mesothelioma. The most common type of this cancer is malignant pleural mesothelioma, which grows…

Largest Study Shows HIPEC Treatment Effective for Mesothelioma
| |

Largest Study Shows HIPEC Treatment Effective for Mesothelioma

Hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) could be an effective treatment for malignant peritoneal mesothelioma (MPM). This is the finding of one of the largest and longest studies on the use of CRS-HIPEC to treat MPM. Researchers from the Atrium Health Wake Forest Baptist Comprehensive Cancer Center looked at data from 111 patients over 28 years. Diagnosed with MPM MPM is an aggressive cancer caused by asbestos. Symptoms of MPM are usually noticed first in the abdomen or the gastrointestinal system. People might feel abdominal pain or swelling, fever, and night sweats. MPM occurs in less than 1,000 people in the United States every year and accounts for about 20-25% of all mesothelioma cases. Patients diagnosed with MPM have longer life expectancy…

Improving Survival in Malignant Pleural Mesothelioma
|

Improving Survival in Malignant Pleural Mesothelioma

Surgery to remove cancer tissue can lead to improved survival for epithelioid malignant pleural mesothelioma (MPM). Patients with sarcomatoid or biphasic malignant pleural mesothelioma did not have the same results. This is the finding of a study that looked at patient data from the National Cancer Database. Worst Prognosis with Standard Therapies MPM is an aggressive cancer that develops in the lining of the lungs. It is caused by exposure to asbestos and is difficult to treat. There are three cell types for this type of cancer: epithelioid, sarcomatoid, and biphasic. About half of malignant mesotheliomas are epithelioid. This type tends to have better treatment outcomes. About 10% of mesotheliomas are sarcomatoid. This type generally has the worst prognosis with…

Mesothelioma Breakthrough Can Spare the Diaphragm
|

Mesothelioma Breakthrough Can Spare the Diaphragm

A new study shows that surgery for malignant pleural mesothelioma can spare the diaphragm without reducing overall survival. This study was conducted by medical researchers from St. Bartholomew’s Hospital in the United Kingdom. Surgery for Malignant Pleural Mesothlioma Mesothelioma is a type of cancer caused by exposure to asbestos. It can take decades after asbestos exposure for the cancer to develop. It is an aggressive cancer and can be hard to treat. When the cancer grows in your lungs, it is called malignant pleural mesothelioma (MPM). Conventional treatment for MPM may include surgery, radiation therapy, and chemotherapy. Surgery is the most invasive treatment option and not every patient is eligible for surgery. If the patient is too ill or if…